Literature DB >> 10799909

Na+-dependent high-affinity glutamate transport in macrophages.

A C Rimaniol1, S Haïk, M Martin, R Le Grand, F D Boussin, N Dereuddre-Bosquet, G Gras, D Dormont.   

Abstract

Excessive accumulation of glutamate in the CNS leads to excitotoxic neuronal damage. However, glutamate clearance is essentially mediated by astrocytes through Na+-dependent high-affinity glutamate transporters (excitatory amino acid transporters (EAATs)). Nevertheless, EAAT function was recently shown to be developmentally restricted in astrocytes and undetectable in mature astrocytes. This suggests a need for other cell types for clearing glutamate in the brain. As blood monocytes infiltrate the CNS in traumatic or inflammatory conditions, we addressed the question of whether macrophages expressed EAATs and were involved in glutamate clearance. We found that macrophages derived from human blood monocytes express both the cystine/glutamate antiporter and EAATs. Kinetic parameters were similar to those determined for neonatal astrocytes and embryonic neurons. Freshly sorted tissue macrophages did not possess EAATs, whereas cultured human spleen macrophages and cultured neonatal murine microglia did. Moreover, blood monocytes did not transport glutamate, but their stimulation with TNF-alpha led to functional transport. This suggests that the acquisition of these transporters by macrophages could be under the control of inflammatory molecules. Also, monocyte-derived macrophages overcame glutamate toxicity in neuron cultures by clearing this molecule. This suggests that brain-infiltrated macrophages and resident microglia may acquire EAATs and, along with astrocytes, regulate extracellular glutamate concentration. Moreover, we showed that EAATs are involved in the regulation of glutathione synthesis by providing intracellular glutamate. These observations thus offer new insight into the role of macrophages in excitotoxicity and in their response to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799909     DOI: 10.4049/jimmunol.164.10.5430

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Activated microglia: the silent executioner in neurodegenerative disease?

Authors:  S H Appel; E P Simpson
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 2.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

Review 3.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

4.  Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice.

Authors:  Martine M Mirrione; Dorothy K Konomos; Iordanis Gravanis; Stephen L Dewey; Adriano Aguzzi; Frank L Heppner; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2010-04-09       Impact factor: 5.996

5.  The cystine/glutamate antiporter regulates dendritic cell differentiation and antigen presentation.

Authors:  June A D'Angelo; Eleonora Dehlink; Barbara Platzer; Peter Dwyer; Magdalena L Circu; Jone Garay; Tak Yee Aw; Edda Fiebiger; Bonny L Dickinson
Journal:  J Immunol       Date:  2010-08-23       Impact factor: 5.422

6.  Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Authors:  Angela M Floden; Shanshan Li; Colin K Combs
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

7.  Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi.

Authors:  Lucinda J Thompson; Sarah J Dunstan; Christiane Dolecek; Tim Perkins; Deborah House; Gordon Dougan; Thi Hue Nguyen; Thi Phi La Tran; Cong Du Doan; Thi Phuong Le; Thi Dung Nguyen; Tinh Hien Tran; Jeremy J Farrar; Denise Monack; David J Lynn; Stephen J Popper; Stanley Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

8.  Differential expression levels of MRP1, MRP4, and MRP5 in response to human immunodeficiency virus infection in human macrophages.

Authors:  Sylvie Jorajuria; Nathalie Dereuddre-Bosquet; Karen Naissant-Storck; Dominique Dormont; Pascal Clayette
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.

Authors:  Kangmin D Lee; Woon N Chow; Carmen Sato-Bigbee; Martin R Graf; Robert S Graham; Raymond J Colello; Harold F Young; Bruce E Mathern
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 10.  Neuroinflammation: the devil is in the details.

Authors:  Damon J DiSabato; Ning Quan; Jonathan P Godbout
Journal:  J Neurochem       Date:  2016-05-04       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.